Regulatory T Cell-Mediated Tissue Repair

Adv Exp Med Biol. 2018:1064:221-233. doi: 10.1007/978-981-13-0445-3_14.

Abstract

Regulatory T-cells (Treg cells) are a specific group of T-cells that maintain immune homeostasis by counteracting the immune responses of conventional T-cells. So far, the therapeutic applications of Treg cells have focused on the treatment of autoimmune diseases, as depletion of Treg cells or Treg-related genes is known to cause autoimmune defects. However, Treg cells can be a potential solution for tissue repair as they can terminate the pro-inflammatory phase and initiate the anti-inflammatory or regenerative phase at the tissue injury site. This review summarizes the known characteristics of Treg cells and lists examples of their therapeutic applications. The use of Treg cells in the treatment of myocardial infarctions, skeletal muscle injuries, and ischemia injuries has revealed their potential as a promising tissue repair method. We have also discussed the limitations and scope of Treg cells in tissue repair.

Keywords: Inflammation; Regulatory T cell; Tissue repair.

Publication types

  • Review

MeSH terms

  • Autoimmune Diseases / therapy*
  • Cell- and Tissue-Based Therapy*
  • Humans
  • Ischemia / therapy
  • Muscle, Skeletal / injuries
  • Myocardial Infarction / therapy
  • Regeneration
  • T-Lymphocytes, Regulatory / cytology*